Literature DB >> 10966941

Age related macular degeneration: could we improve the services we offer?

G N Dutton.   

Abstract

Mesh：

Year:  2000        PMID： 10966941      PMCID： PMC1723644          DOI： 10.1136/bjo.84.9.945

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  2 in total

1.  Cost effectiveness of pegaptanib for the treatment of age-related macular degeneration in the UK.

Authors:  Sorrel E Wolowacz; Neil Roskell; Steven Kelly; Fiona M Maciver; Chris S Brand
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

Review 2.  Quality of life in age-related macular degeneration: a review of the literature.

Authors:  Jan Mitchell; Clare Bradley
Journal:  Health Qual Life Outcomes       Date:  2006-12-21       Impact factor: 3.186
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.